Therapeutic Possibilities of Using an Oxygen-Metabolism Activator (Solcoseryl®) by the Systemic and Topical Route in Ophthalmology
Author(s) -
Feliciana Menna
Publication year - 1980
Publication title -
ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.639
H-Index - 60
eISSN - 1423-0267
pISSN - 0030-3755
DOI - 10.1159/000309080
Subject(s) - medicine , ophthalmology , oxygen metabolism , activator (genetics) , cellular metabolism , metabolism , oxygen , chemistry , receptor , organic chemistry
Therapeutic Possibilities of Using an Oxygen-Metabolism Activator (Solcoseryl) by the Systemic and Topical Route in Ophthalmology Many authors are already interested in the therapeutic use of oxygen. Although its usefulness is recognized, technical difficulties have always restricted wider spread of this practice. G. Goldmann L. Liechti [19] S. Schubert [cited in 19] B. Batencke B. Betastoisky [cited in 18] have shown that in the presence of anoxia the blind spot is enlarged. Bietti S. Sarsanelli [5] F. Ferraris d. de Gasperis [13] have observed that the perimetric deficit in cases of glaucoma improves after the inhalation of oxygen. Bietti
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom